Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration Triggered by Genentech's IND Filing.

Business Wire › June 18, 2008

Linked as:

Extract

Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration Triggered by Genentech's IND Filing.

BOTHELL, Wash. -- Seattle Genetics, Inc. (NASDAQ:SGEN), announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc. The milestone was triggered ...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company

Other documents:

Should elder abuse trigger punitive damages? | 'account for your future' scholarship announced by pro2net, john wiley & sons, kpmg. | C++ Java and SQL Server Experts Among the Most In-Demand in LA-Area Technology Marketplace Reports techies.com. | Fenge Yang v U.S Attorney General 11th Cir 2007 | Sentencia nº 630 de Consiglio di Stato, February 05, 2008 | resolución nº 26566 de corte suprema de chile sala segunda october 16 2007 | Sentencia nº 505 de Consiglio di Stato February 02 2011 | Sentencia nº 4930 de Consiglio di Stato October 27 2010